Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I study.

Sobol, R E; Shawler, D L; Carson, C; Van Beveren, C; Mercola, D; Fakhrai, H; Garrett, M A; Barone, R; Goldfarb, P; Bartholomew, R M; Brostoff, S; Carlo, D J; Royston, I; Gold, D P

Sobol, R E; Shawler, D L; Carson, C; Van Beveren, C; Mercola, D; Fakhrai, H; Garrett, M A; Barone, R; Goldfarb, P; Bartholomew, R M; Brostoff, S; Carlo, D J; Royston, I; Gold, D P.

Affiliation

Sobol RE; Sidney Kimmel Cancer Center, Clemma A. Hewitt Gene Therapy Laboratory, San Diego, California 92121-1181, USA.

Clin Cancer Res ; 5(9): 2359-65, 1999 Sep.

Article in En | MEDLINE | ID: mdl-10499605

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Genetic Therapy / Immunotherapy, Adoptive / Interleukin-2 / Cancer Vaccines / Fibroblasts Type of study: Etiology_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links